A retired surgeon from South Dakota admitted that he lied under oath two decades ago when he testified in a malpractice lawsuit against one of his partners, NPR and ProPublica report.

Patients who developed infective endocarditis after undergoing transcatheter aortic valve replacement (TAVR) had high rates of morbidity and mortality, according to a registry analysis. The in-hospital mortality rate was 36 percent, while the two-year mortality rate was 66.7 percent.

The Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Texas, was the first facility in the country to use a new heart catheter device approved by the FDA in August.

A randomized trial found that patients had similar rates of survival and quality of life whether they underwent elective open and endovascular repair of their aortic abdominal aneurysm (AAA). The procedures also had similar costs and cost-effectiveness ratios.

September 21, 2016 – SpringBoard Healthcare is now taking responses for its nationwide wage survey of nurses, technicians and specialists working in cardiac catheterization, electrophysiology and interventional radiology labs. Considered the gold standard of wage surveys for the industry, it is designed to gather comprehensive insight into the salaries and wages of employees in that sector. The results, based on data from thousands of participants, highlight salary and wage differences by job type, experience, facility type, credentials and state and region.

A study, published this month in the journal Nature Medicine, tested the effects of a molecule called chaer on animals. Results showed that blocking the molecule prevented them from developing heart failure.

After an out-of-hospital cardiac arrest, the use of coronary angiography and PCI increased from 2000 to 2012 among patients with initial rhythms of ventricular tachycardia or pulseless ventricular fibrillation (VT/VF), according to an observational analysis. There was also an improvement in survival to hospital discharge and discharge home.

Medtronic announced new data, demonstrating safety and efficacy at three years in acute complicated Type B aortic dissection patients treated with the Valiant Captivia Thoracic Stent Graft System. Ali Azizzadeh, MD, FACS, University of Texas Health Science Center in Texas presented the new clinical data in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2016.